First OTC Test for Chlamydia, Gonorrhea Approved by the FDA
By Physician’s Briefing Staff HealthDay Reporter
THURSDAY, Nov. 16, 2023 -- On Wednesday, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple 2 Test, the first home test for chlamydia and gonorrhea.
People will be able to buy the Simple 2 Test over-the-counter at a pharmacy, take a specimen at home, and send their sample to a designated laboratory for testing, the FDA said.
The test is produced by LetsGetChecked, a global health care solutions company focused on managing health from home. The company offers the test on its website for $99, and promises results back in two to five days. It is the first FDA-approved test with at-home sample collection for any sexually transmitted disease other than HIV, the agency said.
A person using the Simple 2 Test will provide a sample via vaginal swabs or urine specimens. As part of the approval process, the FDA evaluated data showing that most patients can safely use the kit and have a general understanding of both the results and what they need to do afterward. Users will fill out an online health questionnaire prior to sending off their sample, and their test results will be delivered online. A health care provider will follow up in cases of positive or invalid test results, the FDA said.
The FDA reviewed the Simple 2 Test under a regulatory pathway for new types of devices that are of low-to-moderate risk. The approval creates a new regulatory classification for this type of home test.
Marketing of the Simple 2 Test was granted to LetsGetChecked.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Recommended Treatment for STIs More Likely in Public Versus Private Health Care Settings
TUESDAY, April 30, 2024 -- Individuals seen for sexually transmitted infections (STIs) by clinicians in a private U.S. health care setting are less likely to receive recommended...
Rise in Drug-Resistant Gonorrhea in China May Pose Global Threat
THURSDAY, March 28, 2024 -- Cases of a strain of highly antibiotic-resistant gonorrhea that first emerged in China in 2016 have tripled there in just five years, according to...
2022 Saw More Than 2.5 Million Cases of Chlamydia, Gonorrhea, Syphilis
FRIDAY, Feb. 2, 2024 -- More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the United States in 2022, with concerns centering around syphilis and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.